Ekso Bionics Holdings (LTS:0IFR) Long-Term Capital Lease Obligation : $0.35 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings Long-Term Capital Lease Obligation?

Ekso Bionics Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was $0.35 Mil.

Ekso Bionics Holdings's quarterly Long-Term Capital Lease Obligation declined from Sep. 2024 ($0.56 Mil) to Dec. 2024 ($0.45 Mil) and declined from Dec. 2024 ($0.45 Mil) to Mar. 2025 ($0.35 Mil).

Ekso Bionics Holdings's annual Long-Term Capital Lease Obligation declined from Dec. 2022 ($1.09 Mil) to Dec. 2023 ($0.72 Mil) and declined from Dec. 2023 ($0.72 Mil) to Dec. 2024 ($0.45 Mil).

Ekso Bionics Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for Ekso Bionics Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ekso Bionics Holdings Long-Term Capital Lease Obligation Chart

Ekso Bionics Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.23

1.09

0.72

0.45

Ekso Bionics Holdings Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.63	0.66	0.56	0.45	0.35

Ekso Bionics Holdings (LTS:0IFR) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Ekso Bionics Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

EKSO:USA 23E2:Germany

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings Headlines

No Headlines